These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 24464387)
1. Clinical management of primary aldosteronism: 2013 Practical Recommendations of the Italian Society of Hypertension (SIIA). Rossi GP; Dalla Cà A; High Blood Press Cardiovasc Prev; 2014 Mar; 21(1):71-5. PubMed ID: 24464387 [TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases]. Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213 [TBL] [Abstract][Full Text] [Related]
3. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. Funder JW; Carey RM; Mantero F; Murad MH; Reincke M; Shibata H; Stowasser M; Young WF J Clin Endocrinol Metab; 2016 May; 101(5):1889-916. PubMed ID: 26934393 [TBL] [Abstract][Full Text] [Related]
4. Prediction of successful outcome in patients with primary aldosteronism. Moo TA; Zarnegar R; Duh QY Curr Treat Options Oncol; 2007 Aug; 8(4):314-21. PubMed ID: 18058076 [TBL] [Abstract][Full Text] [Related]
5. Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach. Carey RM Curr Cardiol Rep; 2016 Oct; 18(10):97. PubMed ID: 27566330 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and diagnosis of primary aldosteronism. Rossi GP Curr Hypertens Rep; 2010 Oct; 12(5):342-8. PubMed ID: 20665130 [TBL] [Abstract][Full Text] [Related]
7. Primary aldosteronism: from bench to bedside. Sukor N Endocrine; 2012 Feb; 41(1):31-9. PubMed ID: 22042487 [TBL] [Abstract][Full Text] [Related]
8. Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. Mulatero P; Sechi LA; Williams TA; Lenders JWM; Reincke M; Satoh F; Januszewicz A; Naruse M; Doumas M; Veglio F; Wu VC; Widimsky J J Hypertens; 2020 Oct; 38(10):1929-1936. PubMed ID: 32890265 [TBL] [Abstract][Full Text] [Related]
9. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited. Williams TA; Reincke M Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485 [TBL] [Abstract][Full Text] [Related]
10. Treatment of primary hyperaldosteronism. Araujo-Castro M Med Clin (Barc); 2020 Oct; 155(7):302-308. PubMed ID: 32586668 [TBL] [Abstract][Full Text] [Related]
14. Will the lessons from primary aldosteronism change the treatment of hypertension and left ventricular hypertrophy? Auchus RJ; Drazner MH Hypertension; 2007 Nov; 50(5):837-9. PubMed ID: 17909118 [No Abstract] [Full Text] [Related]
15. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698 [TBL] [Abstract][Full Text] [Related]
17. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism. Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227 [TBL] [Abstract][Full Text] [Related]